Tambocor | Flecainide 50 Mg Breastfeeding

Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Tambocor | Flecainide 50 Mg while breastfeeding. We will also discuss about common side effects and warnings associated with Tambocor | Flecainide 50 Mg.

What is Tambocor | Flecainide 50 Mg used for?


: In patients without structural heart disease, TAMBOCOR is indicated for the prevention of – paroxysmal supraventricular tachycardias (PSVT), including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia and other supraventricular tachycardias of unspecified mechanism associated with disabling symptoms – paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms TAMBOCOR is also indicated for the prevention of – documented ventricular arrhythmias, such as sustained ventricular tachycardia (sustained VT), that in the judgment of the physician are life-threatening. Use of TAMBOCOR for the treatment of sustained VT, like other antiarrhythmics, should be initiated in the hospital. The use of TAMBOCOR is not recommended in patients with less severe ventricular arrhythmias even if the patients are symptomatic. Because of the proarrhythmic effects of TAMBOCOR, its use should be reserved for patients in whom, in the opinion of the physician, the benefits of treatment outweigh the risks. TAMBOCOR should not be used in patients with recent myocardial infarction. (See Boxed Warnings.) Use of TAMBOCOR in chronic atrial fibrillation has not been adequately studied and is not recommended. (See Boxed Warnings.) As is the case for other antiarrhythmic agents, there is no evidence from controlled trials that the use of TAMBOCOR favorably affects survival or the incidence of sudden death.

I am breastfeeding mother and I am using Tambocor | Flecainide 50 Mg. Can it have any bad effect on my kid? Shall I search for better alternative?

Tambocor | Flecainide 50 Mg safe for breastfeeding
As per our analysis Tambocor | Flecainide 50 Mg contains only one ingredient and that is Flecainide. We have analyzed Flecainide and it seems to be safe to use Flecainide while breastfeeding, that means usage of Tambocor | Flecainide 50 Mg shall be safe while breastfeeding. Below you can check more details of Flecainide usage in breastfeeding. We recommend you to go through provided detailed analysis as below take decision accordingly.

Statement of Manufacturer/Labeler about breastfeeding usage
Nursing Mothers. Results from a multiple dose study conducted in mothers soon after delivery indicates that flecainide is excreted in human breast milk in concentrations as high as 4 times (with average levels about 2.5 times) corresponding plasma levels; assuming a maternal plasma level at the top of the therapeutic range (1 μg/mL), the calculated daily dose to a nursing infant (assuming about 700 mL breast milk over 24 hours) would be less than 3 mg.

Tambocor | Flecainide 50 Mg Breastfeeding Analsys


Flecainide while Breastfeeding

Safe

CAS Number: 54143-56-5

Although it is concentrated in the milk, the theoretical dose ingested by the infant does not reach 6% of the therapeutic dose (Wagner 1990, McQuinn 1990), even with a maternal dose as high as 200 mg daily. American Academy of Pediatrics: medication usually compatible with breastfeeding.

Tambocor | Flecainide 50 Mg Breastfeeding Analsys - 2


Flecainide while Breastfeeding

CAS Number: 54143-55-4

Limited information indicates that maternal doses of flecainide up to 200 mg daily produce low levels in milk and would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months. Because of the relative lack of data concerning breastfeeding during maternal flecainide therapy, exclusively breastfed infants should be carefully monitored if this drug is used during lactation, possibly including measurement of serum levels to rule out toxicity if there is a concern.

Is Tambocor | Flecainide 50 Mg safe while breastfeeding

What should I do if already breastfed my kid after using Tambocor | Flecainide 50 Mg?

It is always a good idea to keep your healthcare provider or doctor informed about your drug usage during pregnancy and breastfeeding but if you have not informed your doctor about Tambocor | Flecainide 50 Mg and have used it then do not panic as Tambocor | Flecainide 50 Mg is mostly safe in breastfeeding and should not cause any harm to your baby.


I am nursing mother and my doctor has suggested me to use Tambocor | Flecainide 50 Mg, is it safe?

Usage of Tambocor | Flecainide 50 Mg is safe for nursing mothers and baby, No worries.


If I am using Tambocor | Flecainide 50 Mg, will my baby need extra monitoring?

No


Who can I talk to if I have questions about usage of Tambocor | Flecainide 50 Mg in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week